Optimal Cardiopulmonary Bypass and Anticoagulation Management Strategies in Obese Patients Undergoing Cardiac Surgery
Status:
Recruiting
Trial end date:
2027-12-31
Target enrollment:
Participant gender:
Summary
Standard Heparin management, based on total body weight, is not well established for obese
patients undergoing cardiac surgery with cardiopulmonary bypass (CPB).
The purpose of this study is to assess the safety and efficacy of using lean body mass (LBM)
to determine pump flow rate and/or Heparin dosage in obese patients undergoing CPB.
Phase:
N/A
Details
Lead Sponsor:
Laval University
Collaborator:
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec